This extended series supports that allo-HSCT is able to effectively rescue over one third of the population of patients with advanced-stage MF/SS

Pediatric Hodgkin lymphoma (pHL) is highly curable. However, a minority experience relapse and are subjected to toxic salvage regimens

We performed a pairwise comparative analysis of early response to first- and second-line treatments in 127 patients with classic HL who experienced...

This review describes our approach to the diagnosis of all 4 anaplastic large cell lymphoma (ALCL) entities

Treatment regimens for pediatric Hodgkin's lymphoma (HL) depend on accurate staging and treatment response assessment, based on accurate disease...

This study explores associations between age and BPT in a real-world cohort of largely older patients with HL and finally demonstrates a direct...

MicroRNA-155 (miR-155) may function as a diagnostic biomarker of breast cancer (BC).

To develop a CT texture-based model able to predict epidermal growth factor receptor (EGFR)-mutated, anaplastic lymphoma kinase